Compare Stocks: WAT, BRKR, RGEN, and TECH

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BRKR Bruker	$59.25 +3.8%	$58.78	$28.53 ▼ $65.30	$8.69B	1.28	2.43 million shs	2.43 million shs
RGEN Repligen	$182.03 +1.0%	$151.11	$100.99 ▼ $188.73	$10.18B	1.03	1.02 million shs	611,894 shs
TECH Bio-Techne	$72.47 +0.1%	$70.57	$43.19 ▼ $72.62	$11.35B	1.28	2.99 million shs	1.68 million shs
WAT Waters	$420.35 +1.5%	$386.36	$282.77 ▼ $426.22	$40.69B	1.19	850,263 shs	741,537 shs

7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BRKR Bruker	+3.84%	-1.12%	-5.82%	+0.61%	+76.39%
RGEN Repligen	+0.96%	+0.97%	+25.24%	+46.86%	+53.12%
TECH Bio-Techne	+0.12%	+0.26%	+0.56%	+40.23%	+28.90%
WAT Waters	+1.27%	+3.63%	+9.28%	+9.43%	+42.50%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BRKR Bruker	$59.25 +3.8%	$58.78	$28.53 ▼ $65.30	$8.69B	1.28	2.43 million shs	2.43 million shs
RGEN Repligen	$182.03 +1.0%	$151.11	$100.99 ▼ $188.73	$10.18B	1.03	1.02 million shs	611,894 shs
TECH Bio-Techne	$72.47 +0.1%	$70.57	$43.19 ▼ $72.62	$11.35B	1.28	2.99 million shs	1.68 million shs
WAT Waters	$420.35 +1.5%	$386.36	$282.77 ▼ $426.22	$40.69B	1.19	850,263 shs	741,537 shs

7 Stocks to Buy Before the Robotics Revolution

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BRKR Bruker	+3.84%	-1.12%	-5.82%	+0.61%	+76.39%
RGEN Repligen	+0.96%	+0.97%	+25.24%	+46.86%	+53.12%
TECH Bio-Techne	+0.12%	+0.26%	+0.56%	+40.23%	+28.90%
WAT Waters	+1.27%	+3.63%	+9.28%	+9.43%	+42.50%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BRKR Bruker	2.57	Moderate Buy	$56.64	-4.40% Downside
RGEN Repligen	3.00	Buy	$166.43	-8.57% Downside
TECH Bio-Techne	2.12	Hold	$68.92	-4.89% Downside
WAT Waters	2.80	Moderate Buy	$424.35	0.95% Upside

Current Analyst Ratings Breakdown

Latest WAT, BRKR, RGEN, and TECH Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/27/2026	WAT Waters	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Neutral ➝ Overweight	$400.00 ➝ $480.00
8/25/2026	TECH Bio-Techne	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C-) ➝ Hold (C)
8/25/2026	TECH Bio-Techne	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/19/2026	TECH Bio-Techne	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold
8/13/2026	RGEN Repligen	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D+) ➝ Hold (C-)
8/13/2026	TECH Bio-Techne	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Overweight ➝ Equal Weight	$62.00 ➝ $73.00
8/12/2026	WAT Waters	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C) ➝ Hold (C-)
8/10/2026	WAT Waters	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$425.00 ➝ $470.00
8/5/2026	WAT Waters	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$430.00
8/5/2026	WAT Waters	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold	$400.00
8/5/2026	WAT Waters	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform	$420.00

(Data available from 8/28/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BRKR Bruker	$3.44B	2.63	$3.51 per share	16.90	$15.75 per share	3.76
RGEN Repligen	$785.10M	13.08	$3.45 per share	52.77	$37.42 per share	4.86
TECH Bio-Techne	$1.22B	9.35	$2.35 per share	30.83	$13.44 per share	5.39
WAT Waters	$4.64B	8.89	$16.87 per share	24.91	$154.66 per share	2.72

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BRKR Bruker	-$8.60M	-$0.70	N/A	24.38	1.75	-2.35%	12.47%	4.91%	11/2/2026 (Estimated)
RGEN Repligen	$48.89M	$0.73	249.36	69.74	3.29	5.29%	5.30%	3.79%	11/3/2026 (Estimated)
TECH Bio-Techne	$181.86M	$1.15	63.02	36.05	8.62	14.97%	13.23%	10.61%	11/4/2026 (Estimated)
WAT Waters	$642.63M	$4.01	104.82	25.48	2.41	3.58%	11.27%	6.73%	11/3/2026 (Estimated)

Latest WAT, BRKR, RGEN, and TECH Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/12/2026	Q4 2026	TECH Bio-Techne	$0.5190	$0.52	+$0.0010	$0.35	$314.63 million	$321.19 million
8/4/2026	Q2 2026	BRKR Bruker	$0.3849	$0.49	+$0.1051	-$0.41	$853.57 million	$838.50 million
8/4/2026	Q2 2026	WAT Waters	$3.01	$3.05	+$0.04	-$1.39	$1.62 billion	$1.65 billion
7/28/2026	Q2 2026	RGEN Repligen	$0.4470	$0.54	+$0.0930	$0.09	$201.59 million	$204.13 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BRKR Bruker	$0.20	0.34%	+4.56%	N/A	N/A
RGEN Repligen	N/A	N/A	N/A	N/A	N/A
TECH Bio-Techne	$0.32	0.44%	N/A	27.83%	N/A
WAT Waters	N/A	N/A	N/A	N/A	N/A

Latest WAT, BRKR, RGEN, and TECH Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/14/2026	BRKR Bruker	quarterly	$0.05	0.35%	9/21/2026	9/21/2026	10/7/2026
8/12/2026	TECH Bio-Techne	quarterly	$0.65	0.44%	8/24/2026	8/24/2026	9/4/2026
8/12/2026	TECH Bio-Techne	quarterly	$0.08	0.44%	8/17/2026	8/17/2026	8/28/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BRKR Bruker	0.76	1.85	0.92
RGEN Repligen	0.26	9.05	7.64
TECH Bio-Techne	0.09	4.55	3.35
WAT Waters	0.32	1.86	1.29

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BRKR Bruker	79.52%
RGEN Repligen	97.64%
TECH Bio-Techne	98.95%
WAT Waters	94.01%

Insider Ownership

Company	Insider Ownership
BRKR Bruker	27.20%
RGEN Repligen	0.60%
TECH Bio-Techne	1.30%
WAT Waters	0.31%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BRKR Bruker	11,085	152.36 million	110.92 million	Optionable
RGEN Repligen	2,000	56.44 million	56.10 million	Optionable
TECH Bio-Techne	3,100	156.82 million	154.78 million	Optionable
WAT Waters	7,900	98.25 million	97.94 million	Optionable

WAT, BRKR, RGEN, and TECH Headlines

Recent News About These Companies

Canada Pension Plan Investment Board Has $60.80 Million Stake in Waters Corporation $WAT

1 hour ago | marketbeat.com

Is Wall Street Bullish or Bearish on Waters Corporation Stock?

1 hour ago | barchart.com

Waters (NYSE:WAT) Sets New 52-Week High - Should You Buy?

August 27 at 10:59 AM | marketbeat.com

Pilgrim Global Advisors LLC Makes New $466.13 Billion Investment in Waters Corporation $WAT

August 27 at 5:52 AM | marketbeat.com

For Starry Waters and Tiny Glowing Squids, Head to These Best Places to See Bioluminescence

August 27 at 5:50 AM | cntraveler.comC

Legal & General Group Plc Increases Stock Holdings in Waters Corporation $WAT

August 27 at 5:19 AM | marketbeat.com

OMERS ADMINISTRATION Corp Reduces Position in Waters Corporation $WAT

August 27 at 5:11 AM | marketbeat.com

Cibc World Market Inc. Has $2.28 Million Stock Position in Waters Corporation $WAT

August 27 at 3:52 AM | marketbeat.com

Waters Corporation to Present at the Wells Fargo Healthcare Conference

August 26 at 9:00 AM | prnewswire.com

Jupiter Topco LLC Makes New Investment in Waters Corporation $WAT

August 26 at 6:15 AM | marketbeat.com

J. Goldman & Co LP Purchases 3,190 Shares of Waters Corporation $WAT

August 26 at 6:01 AM | marketbeat.com

Hsbc Holdings PLC Has $148.92 Million Stock Holdings in Waters Corporation $WAT

August 26 at 6:00 AM | marketbeat.com

The Manufacturers Life Insurance Company Decreases Stock Position in Waters Corporation $WAT

August 26 at 5:43 AM | marketbeat.com

Bank of Nova Scotia Sells 3,735 Shares of Waters Corporation $WAT

August 26 at 3:27 AM | marketbeat.com

Ancora Advisors LLC Buys 7,457 Shares of Waters Corporation $WAT

August 26 at 3:05 AM | marketbeat.com

City and Colour, Finneas, Our Lady Peace, Amanda Marshall and Jeff Tweedy Among Performers Announced for 2026 Canadian Songwriters Hall of Fame Induction Ceremony

August 25 at 6:51 AM | financialpost.comF

Parkman Healthcare Partners LLC Purchases 3,759 Shares of Waters Corporation $WAT

August 25 at 6:32 AM | marketbeat.com

Jones Financial Companies Lllp Purchases 54,144 Shares of Waters Corporation $WAT

August 25 at 6:16 AM | marketbeat.com

Sone Capital Management LLC Makes New Investment in Waters Corporation $WAT

August 25 at 6:15 AM | marketbeat.com

Mates of ghost town Newcastle Waters, once North Australia's capital, want it back on the map

August 24, 2026 | msn.com

Osmosis Investment Management UK Ltd Has $10.42 Million Position in Waters Corporation $WAT

August 24, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

WAT, BRKR, RGEN, and TECH Company Descriptions

Bruker NASDAQ:BRKR

$59.25 +2.19 (+3.84%)

Closing price 08/27/2026 04:00 PM Eastern

Extended Trading

$59.16 -0.09 (-0.15%)

As of 04:03 AM Eastern

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Repligen NASDAQ:RGEN

$182.03 +1.73 (+0.96%)

Closing price 08/27/2026 04:00 PM Eastern

Extended Trading

$183.00 +0.97 (+0.53%)

As of 04:01 AM Eastern

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Bio-Techne NASDAQ:TECH

$72.47 +0.09 (+0.12%)

Closing price 08/27/2026 04:00 PM Eastern

Extended Trading

$72.60 +0.13 (+0.18%)

As of 04:08 AM Eastern

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets in the United States, the United Kingdom, rest of Europe, Middle East, and Africa, Greater China, rest of Asia-Pacific, and internationally. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.

Waters NYSE:WAT

$420.35 +6.18 (+1.49%)

Closing price 08/27/2026 03:59 PM Eastern

Extended Trading

$421.26 +0.91 (+0.22%)

As of 04:00 AM Eastern

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest WAT, BRKR, RGEN, and TECH Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest WAT, BRKR, RGEN, and TECH Earnings

Compare Dividends

Latest WAT, BRKR, RGEN, and TECH Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

WAT, BRKR, RGEN, and TECH Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

WAT, BRKR, RGEN, and TECH Company Descriptions

Bruker NASDAQ:BRKR

Repligen NASDAQ:RGEN

Bio-Techne NASDAQ:TECH

Waters NYSE:WAT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools